Praxis Precision Medicines, Inc. Announces Proposed Public Offering tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Praxis Precision Medicines (PRAX) Announces Proposed Share Offering streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
27.03.2024 - BOSTON, March 27, 2024 (GLOBE NEWSWIRE) - Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders .
Praxis' epilepsy drug hits in phase 2, sparking stock rise and plans for next trial fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Praxis Precision Medicines (NASDAQ:PRAX) Hits New 52-Week High at $66.57 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.